이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Bliss GVS Pharma 대차 대조표 상태
재무 상태 기준 확인 6/6
Bliss GVS Pharma 의 총 주주 지분은 ₹10.0B 이고 총 부채는 ₹878.1M, 이는 부채 대 자기자본 비율을 8.8% 로 가져옵니다. 총자산과 총부채는 각각 ₹12.1B 및 ₹2.1B 입니다. Bliss GVS Pharma 의 EBIT는 ₹1.2B 이며 이자보상배율은 18 입니다. ₹2.2B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
8.8%
부채 비율
₹878.07m
부채
| 이자 보상 비율 | 18x |
| 현금 | ₹2.16b |
| 주식 | ₹10.03b |
| 총 부채 | ₹2.11b |
| 총 자산 | ₹12.14b |
최근 재무 상태 업데이트
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25
Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Recent updates
We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?
Sep 04Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?
Aug 17The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More
Aug 04Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)
Aug 04Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Jul 06재무 상태 분석
단기부채: BLISSGVS 의 단기 자산 ( ₹8.1B )이 단기 부채( ₹1.6B ).
장기 부채: BLISSGVS 의 단기 자산( ₹8.1B )이 장기 부채( ₹510.6M ).
부채 대 자본 내역 및 분석
부채 수준: BLISSGVS 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: BLISSGVS 의 부채 대 자기자본 비율은 지난 5년간 15.4% 에서 8.8% 로 감소했습니다.
부채 범위: BLISSGVS 의 부채는 영업 현금 흐름 ( 173.6% )에 의해 잘 충당되었습니다.
이자 보장: BLISSGVS 의 부채에 대한 이자 지급은 EBIT( 18 x 적용 범위)로 잘 충당됩니다.